FDA NDC Directory · JSON-LD · Markdown

Bosentan

NDC 68382-447 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207760
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsBOSENTAN (125 mg/1)
Marketing started20190501
Package count5

External sources

Source: openFDA. Public-domain (CC0).